News & Media

Susan M. Domchek, MD, executive director of the Basser Center for BRCA, discussed the importance of germline testing in breast cancer care.

Susan Domchek, MD highlights her presentation on germline testing & cancer treatment saying, “We’ve learned how useful genetic information can be when deciding on a treatment plan for a patient with breast cancer at several stages of the diagnosis.”

Can we stop cancer before it starts? That’s part of the goal of cancer interception, which involves “catching” cancer cells as they begin to develop into pre-cancers or very early cancers, and halt or reverse that process.

The Basser Center has launched the Men & BRCA program to accelerate research and provide men with specialized BRCA-related care. Dr. Kara Maxwell, Director of the program, says that it will have a focus on education, clinical care & research.

Jacquelyn Powers, MS, LCGC, a genetic counselor at the Basser Center, shares information about genetic counseling and testing services available at the Penn Medicine Mariann and Robert MacDonald Cancer Risk Evaluation Program and at the Center.

Ovarian cancer is known as the silent killer, and Christine Hussey and her mother, Betty Walter, who have both participated in genetic testing at the Basser Center, know the importance of early detection.

Senior study author Katherine Nathanson, MD, the Pearl Basser Professor for BRCA-Related Research and deputy director of the Abramson Cancer Center, discusses what these results might reveal about the mechanisms of cancer recurrence.

Trudy Orthey learned she had a BRCA2 gene mutation after a family member’s cancer diagnosis. Now as a Basser Center patient, Trudy is cancer free and shares her journey with ovarian cancer.

The Basser Center's celebrated their 10th year anniversary with a fundraiser that helps to raise money to find a cure for BRCA-related cancers.

Sara Bareilles shows off her smile while attending the 4th Annual Basser Jean Bash held at The Glasshouse in N.Y.C. on Nov. 15, 2022.